
Journal of Organic Chemistry p. 4873 - 4892 (2019)
Update date:2022-08-04
Topics:
Barnes, David M.
Shekhar, Shashank
Dunn, Travis B.
Barkalow, Jufang H.
Chan, Vincent S.
Franczyk, Thaddeus S.
Haight, Anthony R.
Hengeveld, John E.
Kolaczkowski, Lawrence
Kotecki, Brian J.
Liang, Guangxin
Marek, James C.
McLaughlin, Maureen A.
Montavon, Donna K.
Napier, James J.
Dasabuvir (1) is an HCV polymerase inhibitor which has been developed as a part of a three-component direct-acting antiviral combination therapy. During the course of the development of the synthetic route, two novel coupling reactions were developed. First, the copper-catalyzed coupling of uracil with aryl iodides, employing picolinamide 16 as the ligand, was discovered. Later, the palladium-catalyzed sulfonamidation of aryl nonaflate 33 was developed, promoted by electron-rich palladium complexes, including the novel phosphine ligand, VincePhos (50). This made possible a convergent, highly efficient synthesis of dasabuvir that significantly reduced the mutagenic impurity burden of the process.
View MoreGeen Chemical Technology Co., Ltd
Contact:86-769-21660847
Address:1408, Yingfeng Commercial Center, Nancheng District
Binzhou Holly Pharmaceutical Co.,Ltd.
Contact:74517
Address:No.15 Dapu Road,Huangpu District Shanghai,P.R.China
Lyrin Industrial Corporation Limited
Contact:86-731-82571800
Address:Rm 2408,Asia Economy International Building,Shaoshan Road South,Yuhua District,Changsha,Hunan,China
Xinji City Taida Sinopec Co., Ltd.
Contact:0086-311-85341278
Address:No.6, Nanhua Road,Xinji City Road,Hebei Province,China
Shanghai Demand Chemical Co., ltd,China
Contact:86-021-55237578/55239122
Address:Room 3H, No.578, Yingkou Road, Yangpu District, Shanghai, China
Doi:10.1021/jo5021618
(2014)Doi:10.1021/ja00436a040
(1976)Doi:10.1248/cpb.24.1033
(1976)Doi:10.1007/BF00510097
()Doi:10.1007/BF00904476
(1976)Doi:10.1016/j.tetlet.2011.08.136
(2011)